510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K820192Substantially Equivalent

Haemophilus Influenzae Type B Antiserum

Hyland Therapeutic Div., Travenol Laboratories, Walker MI / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K820192 is the FDA 510(k) clearance record for HAEMOPHILUS INFLUENZAE TYPE B ANTISERUM, a class II device, cleared for Hyland Therapeutic Div., Travenol Laboratories on under FDA product code GRP (Antisera, All Types, H. Influenza). FDA records list 44 510(k) clearances for Hyland Therapeutic Div., Travenol Laboratories, from to . As of , FDA records show no recalls naming K820192.

Clearance record

Decision date
Received
(45 days to decision)
Product code
GRP Antisera, All Types, H. Influenza
Regulation
21 CFR 866.3300
Device class
Class II
Review panel
Microbiology
Applicant
Hyland Therapeutic Div., Travenol Laboratories 4221 Richmond Rd., NW, Walker MI
Third party review
No

Clearances, product code GRP

Trailing 12 months

FDA records hold no clearances under product code GRP in the trailing twelve months.

FDA records show no clearances under product code GRP in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code GRP, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260